AI-powered earnings analysis with management quotes, bull/bear cases, and financial breakdowns for 400+ public companies.
Illumina's earnings reveal a sharp setback, raising doubts over its growth trajectory amidst competitive pressures.
AI's double-edged sword cuts deep as investors question IQVIA's future amid earnings and growing pressures.
KKR's Q4 earnings show strong growth but face the music as AI fears and tariff risks take a toll.
Linde's ballooning sales can't lift shares amid lingering global doubts.
Despite solid growth, investors are wary of the macro hurdles ahead.
Monolithic's solid growth fuels optimism, but will market headwinds dim their bright future?
Despite revenue growth, fears of AI disrupt the payroll party as shares tumble.
With a bright $175M in revenue overshadowed by a stock slide, Qualys faces a tough crowd on the earnings stage.
With a 9.7% stock jump, Roblox’s earnings are a win, but can it sustain the gaming adventure ahead?
Despite a 69.7% revenue leap, investor fears knock Reddit off its subreddit throne.
Despite a solid revenue boost, Rockwell’s outlook raises eyebrows while investors hit the brakes on stock performance.
Sirius XM hits the right notes with modest revenue boosts but faces fierce competition ahead.
Despite a solid $1.6B revenue, Atlassian's stock tumbles as AI challenges loom large.
Thomson Reuters navigates a bumpy AI landscape despite solid growth—can its expertise hold against fierce competition?
Tradeweb Markets' robust Q4 shows it's riding high, but will 2026's challenges keep the momentum going?
Verisign's earnings reveal a chasm between growth potential and investor jitters over AI's impact and costs.
Ventas is riding high on revenue gains, but sustainability questions loom large.
Warner Music hits a high note with $1.8B, but will AI partnerships hit the right pitch?
With a 10% revenue boost, is AbbVie soaring or sinking under pressure?
Despite a revenue dip, Aflac shows resilience as investors find potential amidst the quacking concerns.
Align Technologies braces for 2026 amidst clear aligner debates and a bullish earnings day boost.
Allstate faces a storm of regulatory pressures despite a modest revenue bump; is it time to buckle up?
Arm shows strength in Q4, but can it keep flexing against market obstacles?
Bunge’s soaring revenue clashes with a flat outlook, raising questions in the biofuel debate.